SpinalMotion, developer of the investigational Kineflex® lumbar and Kineflex/C® cervical disc implants for treating patients with DDD, reported that it has submitted the PMA to FDA for the Kineflex lumbar artificial disc. The company also announced that it has secured $27.4 million in Series D funding and reached 20% enrollment for a laterally placed lumbar artificial disc clinical study.
BusinessWire… http://ow.ly/BM26